Daron Evans - 24 May 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role: CEO of Specialty Renal Product
Signature: /s/ Daron Evans
Issuer symbol: NEPH
Transactions as of: 24 May 2021
Net transactions value: +$5,999
Form type: 4
Filing time: 25 May 2021, 15:40:39 UTC
Next filing: 25 Jan 2024
SEC: View on sec.gov

This filing has been restated, see here for the amended filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEPH	Common Stock	Exercise of in-the-money or at-the-money derivative security	$3,000	+1,111	+14%	$2.70	9,296	24 May 2021	By UTMA #1
transaction	NEPH	Common Stock	Exercise of in-the-money or at-the-money derivative security	$3,000	+1,111	+14%	$2.70	9,018	24 May 2021	By UTMA #2
holding	NEPH	Common Stock						134,215	24 May 2021	Direct
holding	NEPH	Common Stock						888	24 May 2021	By UTMA #3
holding	NEPH	Common Stock						888	24 May 2021	By UTMA #4
holding	NEPH	Common Stock						6,111	24 May 2021	By PoC Capital, LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEPH	Common Stock Warrants (Right to Buy)	Exercise of in-the-money or at-the-money derivative security	$0	-1,111	-100%	$0.000000^*	0	24 May 2021	Common Stock	1,111	$2.70	By UTMA #1	F6
transaction	NEPH	Common Stock Warrants (Right to Buy)	Exercise of in-the-money or at-the-money derivative security	$0	-1,111	-100%	$0.000000^*	0	24 May 2021	Common Stock	1,111	$2.70	By UTMA #2	F6
holding	NEPH	Stock Option (Right to Buy)						8,374	24 May 2021	Common Stock	8,374	$4.14	Direct	F2
holding	NEPH	Stock Option (Right to Buy)						242,690	24 May 2021	Common Stock	242,690	$5.40	Direct	F3
holding	NEPH	Stock Option (Right to Buy)						93,014	24 May 2021	Common Stock	93,014	$4.50	Direct	F4
holding	NEPH	Stock Option (Right to Buy)						20,000	24 May 2021	Common Stock	20,000	$8.57	Direct	F5
holding	NEPH	Common Stock Warrants (Right to Buy)						4,630	24 May 2021	Common Stock	4,630	$2.70	By UTMA #1
holding	NEPH	Common Stock Warrants (Right to Buy)						4,630	24 May 2021	Common Stock	4,630	$2.70	By UTMA #2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is a managing director of the LLC that owns the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2	Fully exercisable.
F3	On 4/15/15, the Reporting Person was granted an option to purchase 242,690 shares of common stock of the Company. Options to purchase 84,941 shares vest quarterly in 16 equal amounts commencing on 6/30/15; options to purchase 36,404 shares vested on 8/9/19; and options to purchase 121,345 shares vested upon achievement of previously disclosed performance measures.
F4	On 12/20/17, the Reporting Person was granted an option to purchase 93,014 shares of common stock of the Company. Options to purchase 23,253 shares vested on 12/20/18 and options to purchase 69,761 shares vest quarterly in 12 equal amounts commencing on 3/20/19.
F5	On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.
F6	Previous filings mistakenly reflected this amount as 1,112 shares; the correct amount after appropriate rounding adjustments is 1,111 shares, as reflected above.